- Home
- CVKD vs RMTI Comparison
CVKD vs RMTI Comparison
Compare CVKD & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- RMTI
- Stock Information
- Founded
- CVKD 2022
- RMTI 1994
- Country
- CVKD United States
- RMTI United States
- Employees
- CVKD N/A
- RMTI N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- CVKD Health Care
- RMTI Health Care
- Exchange
- CVKD Nasdaq
- RMTI Nasdaq
- Market Cap
- CVKD 29.5M
- RMTI 32.5M
- IPO Year
- CVKD 2023
- RMTI 1998
- Fundamental
- Price
- CVKD $13.00
- RMTI $1.29
- Analyst Decision
- CVKD Strong Buy
- RMTI Strong Buy
- Analyst Count
- CVKD 1
- RMTI 2
- Target Price
- CVKD $32.00
- RMTI $4.00
- AVG Volume (30 Days)
- CVKD 35.0K
- RMTI 387.7K
- Earning Date
- CVKD 08-06-2025
- RMTI 08-07-2025
- Dividend Yield
- CVKD N/A
- RMTI N/A
- EPS Growth
- CVKD N/A
- RMTI N/A
- EPS
- CVKD N/A
- RMTI N/A
- Revenue
- CVKD N/A
- RMTI $97,727,000.00
- Revenue This Year
- CVKD N/A
- RMTI N/A
- Revenue Next Year
- CVKD N/A
- RMTI $11.16
- P/E Ratio
- CVKD N/A
- RMTI N/A
- Revenue Growth
- CVKD N/A
- RMTI 12.82
- 52 Week Low
- CVKD $5.70
- RMTI $0.78
- 52 Week High
- CVKD $22.90
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- CVKD 49.98
- RMTI 74.79
- Support Level
- CVKD $11.00
- RMTI $0.80
- Resistance Level
- CVKD $13.56
- RMTI $0.87
- Average True Range (ATR)
- CVKD 1.15
- RMTI 0.08
- MACD
- CVKD 0.25
- RMTI 0.05
- Stochastic Oscillator
- CVKD 80.97
- RMTI 79.69
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.